Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy

Author:

Zargar Homayoun1,Shah Jay B.2,van Rhijn Bas W.3,Daneshmand Siamak4,Bivalacqua Trinity J.5,Spiess Philippe E.6,Black Peter C.1,Kassouf Wassim7,

Affiliation:

1. Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada

2. Department of Urology, M. D. Anderson Cancer Center, Houston, Texas

3. Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

4. Institute of Urology, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California

5. Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland

6. Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

7. Division of Urology, Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3